Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadratus Lumborum Block for Percutaneous Nephrostomy
NCT02121951Phase 4Withdrawn
- Sponsor
- National Cancer Institute
- Start
- May 2014
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of levobupivacaine in procedural pain, sponsored by National Cancer Institute. Primary endpoint: Analgesia at 4 hours. Planned start May 2014; status: withdrawn.
02
Drugs
levobupivacaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT02121951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02121951.